Research in Dallas
Science Explorer records 3 research institutions in Dallas. The largest by output are Harold C. Simmons Comprehensive Cancer Center, Comerica (United States) and CBRE Group (United States).
- Research institutions
- 3
- Research works
- 257 ▲ 70% vs 2013–17
- Top-10% rate, 2022–2025
- 26.0% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Dallas?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Harold C. Simmons Comprehensive Cancer CenterHospital / health system | 221 | #15,696 all time | |
| 2 | Comerica (United States)Company | 35 | not ranked | |
| 3 | CBRE Group (United States)Company | 1 | not ranked |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
Which keywords describe research in Dallas?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Prognostic Factors, Cancer, Targeted Therapy, Lymphoma, Breast Cancer and Clinical Trials.
- Nephron-Sparing Surgery
- CDK4/6 Inhibitors
- Radiotherapy
- Classification
- Neoadjuvant Therapy
- Immune Checkpoint Blockade
- CAR T Cells
- Metastatic
- Metastasis
- Gene Expression Profiling
- Cancer Immunotherapy
- Mutational Signatures
- Clinical Practice Guidelines
- Therapy
- Genetic Mutations
- Molecular Characterization
- Clinical Trials
- Lymphoma
- Cancer
- Chemotherapy
- Immunotherapy
- Prognostic Factors
- Targeted Therapy
- Breast Cancer
- Tumor Microenvironment
- Rituximab
- PET Imaging
- Cancer Genomics
- Molecular Profiling
- Tumor Regression
- Clinical Guidelines
- Leukemia
- Cancer Incidence
- Biomarkers
- Chimeric Antigen Receptor
- Metastatic Breast Cancer
- PD-1 and PD-L1
- Genetic Pathogenesis
- Signaling
- Palbociclib
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy5▲ 17×16 topics
- Chemotherapy4▲ 15×21 topics
- Prognostic Factors4▲ 21×12 topics
- Cancer4▲ 6.2×22 topics
- Targeted Therapy3▲ 33×4 topics
- Lymphoma3▲ 40×3 topics
- Breast Cancer2▲ 26×7 topics
- Clinical Trials2▲ 8.9×7 topics
- Tumor Microenvironment2▲ 13×7 topics
- Molecular Characterization2▲ 26×4 topics
- Rituximab2▲ 28×2 topics
- Genetic Mutations2▲ 9.5×9 topics
- PET Imaging2▲ 23×4 topics
- Therapy2▲ 20×4 topics
- Cancer Genomics2▲ 52×1 topic
- Clinical Practice Guidelines2▲ 6.8×8 topics
- Molecular Profiling2▲ 38×3 topics
- Mutational Signatures2▲ 52×1 topic
- Tumor Regression2▲ 36×2 topics
- Cancer Immunotherapy2▲ 23×3 topics
- Clinical Guidelines2▲ 12×5 topics
- Gene Expression Profiling2▲ 44×2 topics
- Leukemia2▲ 42×2 topics
- Metastasis2▲ 10×9 topics
- Cancer Incidence1▲ 24×4 topics
- Metastatic1▲ 54×2 topics
- Biomarkers1▲ 4.6×5 topics
- CAR T Cells1▲ 43×1 topic
- Chimeric Antigen Receptor1▲ 43×1 topic
- Immune Checkpoint Blockade1▲ 27×1 topic
- Metastatic Breast Cancer1▲ 54×2 topics
- Neoadjuvant Therapy1▲ 13×5 topics
- PD-1 and PD-L11▲ 27×1 topic
- Classification1▲ 6.4×1 topic
- Genetic Pathogenesis1▲ 54×1 topic
- Radiotherapy1▲ 7.3×8 topics
- Signaling1▲ 50×3 topics
- CDK4/6 Inhibitors1▲ 110×1 topic
- Palbociclib1▲ 110×1 topic
- Nephron-Sparing Surgery1▲ 72×1 topic
What research is done in Dallas?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 2 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 3 CAR-T cell therapy research Oncology 1 works
- 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
- 6 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 1 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 8 Renal and related cancers Molecular Biology 1 works
- 9 Lung Cancer Research Studies Oncology 1 works
- 10 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.